Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
19542-0 Mescaline PrThr Urine Pt Ord Screen   ACTIVE Mescaline [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19542-0   Screen     Both       0 Mescaline Ur Ql Scn           DRUG/TOXICOLOGY; Drugs; Ordinal; Peyote; Peyotl; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19543-8 Mescaline PrThr Urine Pt Ord Confirm   ACTIVE Mescaline [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19543-8   Confirm     Both       0 Mescaline Ur Ql Cfm           Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Ordinal; Peyote; Peyotl; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19544-6 Mescaline cutoff MCnc Urine Pt Qn Screen   ACTIVE Mescaline cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19544-6   Screen     Observation       0 Mescaline CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Peyote; Peyotl; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19545-3 Mescaline cutoff MCnc Urine Pt Qn Confirm   ACTIVE Mescaline cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19545-3   Confirm     Observation       0 Mescaline CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Peyote; Peyotl; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19546-1 Mesoridazine PrThr Urine Pt Ord Screen   ACTIVE Mesoridazine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19546-1   Screen     Both       0 Mesoridazine Ur Ql Scn           DRUG/TOXICOLOGY; Drugs; Mesoridazine besylate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Serentil; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19547-9 Mesoridazine PrThr Urine Pt Ord Confirm   ACTIVE Mesoridazine [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19547-9   Confirm     Both       0 Mesoridazine Ur Ql Cfm           Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Mesoridazine besylate; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serentil; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19548-7 Mesoridazine cutoff MCnc Urine Pt Qn Screen   ACTIVE Mesoridazine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19548-7   Screen     Observation       0 Mesoridazine CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Mesoridazine besylate; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; Serentil; UA; UR; Urn 2.44 1.0l               ng/mL       0
19549-5 Mesoridazine cutoff MCnc Urine Pt Qn Confirm   ACTIVE Mesoridazine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19549-5   Confirm     Observation       0 Mesoridazine CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Mesoridazine besylate; Point in time; QNT; Quan; Quant; Quantitative; Random; Serentil; UA; UR; Urn 2.44 1.0l               ng/mL       0
1955-4 Beta-N-acetylhexosaminidase CCnt Tiss Pt Qn     ACTIVE Beta-N-acetylhexosaminidase [Enzymatic activity/mass] in Tissue   MIN DefinitionDescription     U/g protein             CHEM   1955-4         Both       0 B-NAH Tiss-cCnt       Y   B; B-NAH; Catalytic Content; Chemistry; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; Tay Sachs Disease; Tissue; Tissue, unspecified 2.42 1               U/g{protein}       0
19550-3 Methadone PrThr Urine Pt Ord Screen   ACTIVE Methadone [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19550-3   Screen     Both       0 Methadone Ur Ql Scn           Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UniversalLabOrders; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19552-9 Methadone cutoff MCnc Urine Pt Qn Screen   ACTIVE Methadone cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19552-9   Screen     Observation       0 Methadone CtO Ur Scn-mCnc       Y   CtO; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; METD; Methadose; MTD; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.73 1.0l               ng/mL       0
19553-7 Methadone cutoff MCnc Urine Pt Qn Confirm   ACTIVE Methadone cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19553-7   Confirm     Observation       0 Methadone CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; METD; Methadose; MTD; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l               ng/mL       0
19554-5 Methamphetamine PrThr Urine Pt Ord Screen   ACTIVE Methamphetamine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19554-5   Screen     Both       0 Methamphet Ur Ql Scn           Addiction; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Methamphet; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19555-2 Methamphetamine PrThr Urine Pt Ord Confirm   ACTIVE Methamphetamine [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19555-2   Confirm     Both       0 Methamphet Ur Ql Cfm           Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; LC/MS/MS; Methamphet; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19556-0 Methamphetamine cutoff MCnc Urine Pt Qn Screen   ACTIVE Methamphetamine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19556-0   Screen     Observation       0 Methamphet CtO Ur Scn-mCnc       Y   CtO; Desoxyn; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Methamphet; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.73 1.0l               ng/mL       0
19557-8 Methamphetamine cutoff MCnc Urine Pt Qn Confirm   ACTIVE Methamphetamine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19557-8   Confirm     Observation       0 Methamphet CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; Desoxyn; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Methamphet; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.73 1.0l               ng/mL       0
19558-6 Methaqualone PrThr Urine Pt Ord Screen   ACTIVE Methaqualone [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19558-6   Screen     Both       0 Methaqualone Ur Ql Scn           Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Methaqualon; Ordinal; Point in time; PotentialForAbuse; PR; QL; Quaalude; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19559-4 Methaqualone cutoff MCnc Urine Pt Qn Screen   ACTIVE Methaqualone cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19559-4   Screen     Observation       0 Methaqualone CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Methaqualon; Point in time; QNT; Quaalude; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.73 1.0l               ng/mL       0
1956-2 Beta-N-acetylhexosaminidase.A CCnc Ser/Plas Pt Qn     ACTIVE Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/mL/H             CHEM   1956-2         Both       0 Hexosaminidase A SerPl-cCnc       Y   B; Beta-hexosaminidase subunit alpha; B-NAH; Catalytic Concentration; Chemistry; GM2 Gangliosidoses; GM2-gangliosidosis; Hex A; Hex B; HEXA; Hexosaminidase; Hexosaminidase A; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Sandhoff disease; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tay Sachs Disease 2.73 1               nmol/mL/h       0
19560-2 Methaqualone cutoff MCnc Urine Pt Qn Confirm   ACTIVE Methaqualone cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19560-2   Confirm     Observation       0 Methaqualone CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; Methaqualon; Point in time; QNT; Quaalude; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19561-0 Methylenediamine PrThr Urine Pt Ord Screen   ACTIVE Methylenediamine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19561-0   Screen     Both       0 Me-enediam Ur Ql Scn           DRUG/TOXICOLOGY; Drugs; MDA; Me-enediam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.56 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19562-8 Methylenediamine PrThr Urine Pt Ord Confirm   ACTIVE Methylenediamine [Presence] in Urine by Confirmatory method   MIN DefinitionDescription                   DRUG/TOX   19562-8   Confirm     Both       0 Me-enediam Ur Ql Cfm           Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; MDA; Me-enediam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
19563-6 Methylenediamine cutoff MCnc Urine Pt Qn Screen   ACTIVE Methylenediamine cutoff [Mass/volume] in Urine for Screen method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19563-6   Screen     Observation       0 Me-enediam CtO Ur Scn-mCnc       Y   CtO; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MDA; Me-enediam; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn 2.44 1.0l               ng/mL       0
19564-4 Methylenediamine cutoff MCnc Urine Pt Qn Confirm   ACTIVE Methylenediamine cutoff [Mass/volume] in Urine for Confirmatory method   MIN DefinitionDescription     ng/mL             DRUG/TOX   19564-4   Confirm     Observation       0 Me-enediam CtO Ur Cfm-mCnc       Y   Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; CtO; DRUG/TOXICOLOGY; Drugs; GCMS; LC/MS/MS; Level; Mass concentration; MDA; Me-enediam; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn 2.44 1.0l               ng/mL       0
19565-1 Methylenedioxyamphetamine PrThr Urine Pt Ord Screen   ACTIVE Methylenedioxyamphetamine [Presence] in Urine by Screen method   MIN DefinitionDescription                   DRUG/TOX   19565-1   Screen     Both       0 MDA Ur Ql Scn           Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; MDA; Methylenedioxymethamphetamine metabolite; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn 2.73 1.0l                     The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found